Microbial DNA synthesis

"Microbial DNA synthesis" is not a specific molecular target but rather refers to the **entire biological process by which microorganisms such as bacteria replicate their genetic material**. This complex pathway involves multiple enzymes and protein factors working in concert. Key components include: • **DNA polymerases** – catalyze the addition of nucleotides during strand elongation[1][3][5][7]. • **Primase** – synthesizes short RNA primers required for initiation on both leading and lagging strands[1][3][5]. • **Helicase** – unwinds double-stranded DNA at the replication fork[1][5][7]. • **Topoisomerase/DNA gyrase** – relieves supercoiling tension ahead of the fork[1][5][7]. • **Single-stranded binding proteins** – stabilize unwound template strands[1]. • **DNA ligase** – seals nicks between Okazaki fragments on the lagging strand after primer removal and replacement with DNA[1][5]. The process is essential for cell division in all microbes. Many antibiotics exploit this necessity by targeting specific enzymes within this pathway—most notably bacterial topoisomerases/gyrases or, less commonly, primases or polymerases themselves. Because "Microbial DNA synthesis" describes an entire pathway rather than a discrete molecular entity such as an enzyme or receptor, it is not considered a canonical therapeutic target itself but rather encompasses several validated targets within its steps. Therefore, it should be flagged as incorrect if used as a single druggable entity. If you are seeking structured data about individual drug targets within microbial DNA synthesis—such as "DNA gyrase," "bacterial primase," or "bacterial type II topoisomerase"—those would be appropriate canonical forms for therapeutic targeting.[1][3][5][7]

Other names

Bacterial DNA replicationProkaryotic DNA synthesisMicrobial genome replication

Inhibition of topoisomerases/gyrases to prevent supercoiling and strand separation[7] - Inhibition of primase or polymerases to block chain elongation[1][3][5]